Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma

计划入组 82 人 · 首次发布于 2008 年 11 月 25 日

Liver Transplantation for Cholangiocarcinoma

计划入组 5 人 · 首次发布于 2008 年 7 月 2 日

Advanced or Metastatic Cholangiocarcinoma

计划入组 60 人 · 首次发布于 2022 年 12 月 16 日

cholangiocarcinoma therapy

iNKT cell-based immunotherapy (cholangiocarcinoma)

Futibatinib(Lytgobi 20 Mg Daily Dose, Lytgobi)

C₂₂H₂₂N₆O₃

Zenocutuzumab Shows 37% Response Rate in Rare NRG1-Positive Cholangiocarcinoma

FDA Grants Orphan Drug Designation to Certepetide for Cholangiocarcinoma

Real-World Data Confirm Ivosidenib Efficacy in IDH1-Mutated Cholangiocarcinoma